The rising usage of GLP-1 weight-loss drugs is having a substantial impact on apparel industry trends as shoppers change sizes and lifestyle habits, according to a Circana report. With some 23% of all ...

The GLP-1 revolution shows no signs of slowing down. A pill version of the appetite-suppressing drug, Wegovy, hit the shelves of 70,000 U.S. pharmacies in January 2026. In the same month, UK-based ...

On Jan. 14, Eli Lilly released its guidance for the fourth quarter of 2024, as well as the full year of 2025. And investors weren't thrilled with the numbers, leading to a 7% drop in the share price ...

Eli Lilly (NYSE: LLY) has become a beast in healthcare. The excitement surrounding its GLP-1 drugs, Mounjaro and Zepbound, has helped boost its market capitalization to around $650 billion. Over the ...

Glucagon-like peptide-1 (GLP-1) receptor agonists are incretin analogues that promote glucose-mediated insulin release and are used to treat type 2 diabetes mellitus and obesity. GLP-1 receptor ...

There’s a lot to consider before starting or stopping a GLP-1 medication. This wellness retreat lays it all on the table.